PATENT CLAIM ANALYSIS

Application Number: 15912103
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "400000"]

Abstract:
Disclosed is a device and method for treating a neurodegenerative disease or condition associated with neuroinflammation induced by a leukotriene. The device is a film unit dosage form having a film layer and a safe and effective amount of a leukotriene receptor antagonist or leukotriene synthesis inhibitor. The device is configured and formulated to achieve transmucosal and/or enteral delivery of the leukotriene receptor antagonist or leukotriene synthesis inhibitor. The method includes transmucosally and/or enterally delivering to an animal in need of treatment, a safe and effective amount of a leukotriene blocker capable of crossing the blood-brain barrier.

Claim (Index 2):
The dosage form of  claim 1 , wherein the penetration enhancing agent is selected from 2,3-lauryl ether phosphatidylcholine, aprotinin, polyoxyethylene, azone, polysorbate 80, benzalkonium chloride, polyoxyethylene, cetylpyridinium chloride, phosphatidylcholine, cetyltrimethyl ammonium bromide, sodium EDTA, cyclodextrin, sodium glycocholate, dextran sulfate 16 sodium glycodeoxycholate, surfactants, bile salts, pore forming agents, and alcohols.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 90.0
- Lexical Diversity: 1.75862
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15299054', '15281144', '15588897', '12666491', '11724410']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7241729544239142
- 35 USC 102 Novelty (BERT): 0.5512744042068503
- Combined Prediction Score: 0.7068830994022078
- Mean Citation Score: 226.38314
- Max Citation Score: 415.47818
- Similarity Product: 320.8495313336564

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test